Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Overview of attention for article published in Cancer Management and Research, October 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,631 followers.

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2. https://t.co/5VnKQpuGYd

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.